HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Niraj Shenoy Selected Research

Renal Cell Carcinoma (Grawitz Tumor)

1/2021Immune evasion in renal cell carcinoma: biology, clinical translation, future directions.
1/2021Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.
1/2019Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma.
1/2019Epigenetic dysregulation by aberrant metabolism in renal cell carcinoma can be reversed with Ascorbic acid.
12/2018Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?
1/2017Drugs with anti-oxidant properties can interfere with cell viability measurements by assays that rely on the reducing property of viable cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Niraj Shenoy Research Topics

Disease

11Neoplasms (Cancer)
10/2020 - 06/2012
6Renal Cell Carcinoma (Grawitz Tumor)
01/2021 - 01/2017
2Hypoxia (Hypoxemia)
01/2020 - 08/2014
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2018 - 08/2014
2Prostatic Neoplasms (Prostate Cancer)
10/2016 - 06/2016
2Carcinogenesis
01/2014 - 06/2012
1Kidney Neoplasms (Kidney Cancer)
01/2021
1Ewing Sarcoma (Sarcoma, Ewing)
12/2020
1Carcinoma (Carcinomatosis)
12/2020
1COVID-19
01/2020
1Lymphoma (Lymphomas)
01/2020
1Disease Progression
06/2016
1Neurosarcoidosis
08/2015
1Lymphadenopathy
08/2015
1Deglutition Disorders (Dysphagia)
08/2015
1Granuloma
08/2015
1Sarcoidosis (Schaumann Disease)
08/2015
1Iron Overload
08/2014
1Thalassemia
08/2014
1Adenocarcinoma
01/2014
1Inflammation (Inflammations)
01/2014
1Esophageal Neoplasms (Esophageal Cancer)
01/2014
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2012

Drug/Important Bio-Agent (IBA)

4Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2020 - 11/2018
25-hydroxymethylcytosineIBA
01/2020 - 01/2019
2DNA (Deoxyribonucleic Acid)IBA
12/2018 - 06/2016
2LigandsIBA
01/2017 - 01/2014
2AndrogensIBA
10/2016 - 06/2016
1Succinic Acid (Succinate)IBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Succinate Dehydrogenase (Fumarate Reductase)IBA
01/2021
1ProteomeIBA
10/2020
1Oxygen (Dioxygen)IBA
01/2020
1Oxidoreductases (Dehydrogenase)IBA
01/2019
1CytosineIBA
01/2019
15-Methylcytosine (5 Methylcytosine)IBA
01/2019
1Ketoglutaric Acids (Ketoglutaric Acid)IBA
01/2019
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
11/2018
1PlatinumIBA
08/2017
1Indicators and Reagents (Reagents)IBA
01/2017
1AntioxidantsIBA
01/2017
1Hormones (Hormone)IBA
10/2016
1Biomarkers (Surrogate Marker)IBA
06/2016
1Cell-Free Nucleic AcidsIBA
06/2016
1Docetaxel (Taxotere)FDA Link
06/2016
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2015
1Adrenal Cortex Hormones (Corticosteroids)IBA
08/2015
1BariumIBA
08/2015
1Intravenous Immunoglobulins (IVIG)FDA Link
08/2015
1Transcription Factors (Transcription Factor)IBA
08/2014
1IronIBA
08/2014
1HepcidinsIBA
08/2014
1Interleukin-8 (Interleukin 8)IBA
01/2014
1ChemokinesIBA
01/2014
1Interleukin-8B ReceptorsIBA
01/2014
1RicinIBA
10/2012
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2012
1Immunotoxins (Immunotoxin)IBA
10/2012
1combotoxIBA
10/2012
1Ribosomal Proteins (Ribosomal Protein)IBA
06/2012

Therapy/Procedure

7Therapeutics
01/2021 - 10/2012
2Drug Therapy (Chemotherapy)
10/2016 - 06/2016
1Combination Drug Therapy (Combination Chemotherapy)
12/2020
1Nephrectomy
12/2018
1Muscle Denervation
08/2015
1Chelation Therapy (Therapy, Chelation)
08/2014